Granuloma formation in the different phenotypes of Crohn's disease

Affiliations

Comment

F Hofstaedter. Gut. 2005 Feb.

. 2005 Feb;54(2):180-1.

doi: 10.1136/gut.2004.048082.

¹ Institute of Pathology, University of Regensburg, F J Strauss Allee 11, Regensburg D 93042, Germany. ferdinand.hofstaedter@klinik.uni-regensburg.de

No abstract available

Comment on

Frequency and significance of granulomas in a cohort of incident cases of Crohn's disease.
Heresbach D, Alexandre JL, Branger B, Bretagne JF, Cruchant E, Dabadie A, Dartois-Hoguin M, Girardot PM, Jouanolle H, Kerneis J, Le Verger JC, Louvain V, Politis J, Richecoeur M, Robaszkiewicz M, Seyrig JA; ABERMAD (Association Bretonne d'Etude et de Recherche sur les Maladies de l'Appareil Digestif). Heresbach D, et al. Gut. 2005 Feb;54(2):215-22. doi: 10.1136/gut.2004.041715. Gut. 2005. PMID: 15647184 Free PMC article.
Epithelioid granulomas, pattern recognition receptors, and phenotypes of Crohn's disease.
Pierik M, De Hertogh G, Vermeire S, Van Assche G, Van Eyken P, Joossens S, Claessens G, Vlietinck R, Rutgeerts P, Geboes K. Pierik M, et al. Gut. 2005 Feb;54(2):223-7. doi: 10.1136/gut.2004.042572. Gut. 2005. PMID: 15647186 Free PMC article.

1. Taylor KD, Rotter JI, Yang H. Genetics of inflammatory bowel disease. In: Targan SR, Shanahan F, Karp LC, eds. Inflammatory bowel disease:from bench to bedside, 2nd edn. Dordrecht: Kluwer Academic 2003:21–65.
1. Targan SR, Hanauer SB, Vandeventer SJH, et al. A short term study of chimeric monoclonal antibody Ca2 to tumor necrosis factor alpha for Crohn’s disease. N Engl J Med 1997;337:1029–35. - PubMed
1. Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease. Nature 2001;411:599–603. - PubMed
1. Ogura Y , Bonen DK, Inohara N, et al. A frame shift mutation in NOD2 associated with susceptibility to Crohn’s disease. Nature 2001;411:603–6. - PubMed
1. Cario E , Podolsky DK. Differential alteration in intestinal epithelial cell expressions of Toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect Immun 2000;68:7010–17. - PMC - PubMed